2016 ◽
Vol 27
◽
pp. vi245
J.S. de Bono
◽
A.-C. Hardy-Bessard
◽
C.S. Kim
◽
L. Géczi
◽
D. Ford
◽
...
2018 ◽
Vol 19
(10)
◽
pp. 1404-1416
◽
Fred Saad
◽
David Cella
◽
Ethan Basch
◽
Boris A Hadaschik
◽
Paul N Mainwaring
◽
...
2017 ◽
Vol 28
◽
pp. v280-v281
M. Eisenberger
◽
A-C. Hardy-Bessard
◽
C.S. Kim
◽
L. Géczi
◽
D. Ford
◽
...
2015 ◽
Vol 16
(5)
◽
pp. 509-521
◽
Yohann Loriot
◽
Kurt Miller
◽
Cora N Sternberg
◽
Karim Fizazi
◽
Johann S De Bono
◽
...
Nancy Devlin
◽
Michael Herdman
◽
Marco Pavesi
◽
De Phung
◽
Shevani Naidoo
◽
...
2015 ◽
Vol 15
(6)
◽
pp. 941-949
◽
Abigail Gee
◽
Amarnath Challapalli
◽
Amit Bahl
Angelika Pichler
◽
Gisoo Barnes
◽
Jana Katolicka
◽
Hana Korunkova
◽
Antoaneta Tomova
◽
...
2021 ◽
Vol 32
◽
pp. S627-S628
K. Fizazi
◽
K. Herrmann
◽
B.J. Krause
◽
K. Rahbar
◽
K.N. Chi
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5010-5010
◽
Gerhardt Attard
◽
Fred Saad
◽
Bertrand F. TOMBAL
◽
Maha Hussain
◽
Cora N. Sternberg
◽
...
2013 ◽
Vol 16
(3)
◽
pp. A146-A147
◽
Y. Hao
◽
C. Evans
◽
S. Hwang
2021 ◽
Vol 154
◽
pp. 138-146
Matthew R. Smith
◽
Neal Shore
◽
Teuvo L. Tammela
◽
Albertas Ulys
◽
Egils Vjaters
◽
...
Close
Export Citation Format
Close
Share Document
Close
PROSELICA: Health-related quality of life (HRQL) and post-hoc analyses for the phase 3 study assessing cabazitaxel 20 (C20) vs 25 (C25) mg/m2 post-docetaxel (D) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
